Strategic Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $696K | Buy |
+1,717
| New | +$696K | 0.05% | 179 |
|
|
2024
Q4 | $1.38M | Sell |
2,588
-28
| -1% | -$14.9K | 0.11% | 124 |
|
|
2024
Q3 | $1.62M | Buy |
2,616
+21
| +0.8% | +$13K | 0.16% | 109 |
|
|
2024
Q2 | $1.44M | Sell |
2,595
-93
| -3% | -$51.4K | 0.15% | 109 |
|
|
2024
Q1 | $1.56M | Sell |
2,688
-15
| -0.6% | -$8.72K | 0.17% | 99 |
|
|
2023
Q4 | $1.43M | Sell |
2,703
-76
| -3% | -$40.3K | 0.18% | 106 |
|
|
2023
Q3 | $1.41M | Buy |
2,779
+6
| +0.2% | +$3.04K | 0.19% | 132 |
|
|
2023
Q2 | $1.45M | Sell |
2,773
-264
| -9% | -$138K | 0.19% | 129 |
|
|
2023
Q1 | $1.75M | Sell |
3,037
-273
| -8% | -$157K | 0.27% | 102 |
|
|
2022
Q4 | $1.82M | Buy |
3,310
+84
| +3% | +$46.3K | 0.34% | 88 |
|
|
2022
Q3 | $1.64M | Sell |
3,226
-49
| -1% | -$24.9K | 0.35% | 98 |
|
|
2022
Q2 | $1.78M | Sell |
3,275
-208
| -6% | -$113K | 0.38% | 87 |
|
|
2022
Q1 | $2.06M | Sell |
3,483
-239
| -6% | -$141K | 0.4% | 87 |
|
|
2021
Q4 | $2.48M | Sell |
3,722
-51
| -1% | -$34K | 0.47% | 67 |
|
|
2021
Q3 | $2.16M | Buy |
3,773
+550
| +17% | +$314K | 0.63% | 37 |
|
|
2021
Q2 | $1.63M | Buy |
3,223
+2,471
| +329% | +$1.25M | 0.53% | 44 |
|
|
2021
Q1 | $343K | Sell |
752
-1,890
| -72% | -$862K | 0.14% | 159 |
|
|
2020
Q4 | $1.23M | Sell |
2,642
-83
| -3% | -$38.7K | 0.52% | 59 |
|
|
2020
Q3 | $1.2M | Sell |
2,725
-715
| -21% | -$316K | 0.61% | 45 |
|
|
2020
Q2 | $1.25M | Buy |
+3,440
| New | +$1.25M | 0.64% | 44 |
|
|
2018
Q3 | – | Sell |
-13
| Closed | -$3K | – | 698 |
|
|
2018
Q2 | $3K | Hold |
13
| – | – | ﹤0.01% | 676 |
|
|
2018
Q1 | $3K | Buy |
+13
| New | +$3K | ﹤0.01% | 697 |
|